In case you missed it, this week we talked about diversity in aesthetics, a new injectable filler approval for chin augmentation and more.
This week in aesthetics, a recent ASPS survey shows positive attitude towards cosmetic surgery during COVID-19, Soliton sees positive cellulite clinical trial results, we discuss the need for diversity in aesthetics and JUVÉDERM® VOLUMA™ XC is approved for chin augmentation. We give you a snapshot of ISHRS’s survey on hair restoration, Sciton unveils their mJOULE platform featuring MOXI and BBL HERO and stem cell facials get a highlight.
Consumer Attitudes of Cosmetic Surgery During COVID-19
A recent survey gauges consumer attitudes toward aesthetic procedures in the wake of the coronavirus pandemic.
Soliton Announces Positive Cellulite Clinical Trial Results
Soliton’s pivotal clinical trial for cellulite using its RAP device shows positive results
Efforts to diversify medical specialties, including aesthetics and dermatology, are gaining momentum on both a local and national level, but more work is needed
JUVÉDERM® VOLUMA™ XC Approved for Chin Augmentation
Allergan announces the FDA approval of JUVÉDERM® VOLUMA™ XC for use in the chin region to improve the chin profile
Facts and Trends in Hair Restoration
A snapshot of notable facts and trends in hair restoration based on the International Society of Hair Restoration Surgery's latest member survey.
Sciton Unveils mJOULE Platform Featuring MOXI and BBL HERO
Sciton recently announced its new platform, mJOULE, featuring a new non-ablative fractional treatment and IPL technology for treating sun damage and anti-aging
The Stem Cell Recruitment Facial
Stem cells in a facial? That was our question too.